Pancreatic Cancer Research

ResearcherKochi Health Sciences CenterActive in the last 2 years

Manabu Matsumoto

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5077697853. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Does Recurrent Pancreatic Cancer Have Similar Outcomes Compared With Primary Metastatic Pancreatic Cancer? Co-author DOI 10.1002/jso.70222↗
  2. Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancer. Co-author DOI 10.1259/bjr.20170165↗
  3. Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portosplenomesenteric venous invasion. Last author DOI 10.1007/s00423-015-1305-z↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jun Iwata · 3 shared papers, 2015–2026 · strength 0.40
  2. Takehiro Okabayashi · 3 shared papers, 2015–2026 · strength 0.40
  3. Tatsuo Iiyama · 3 shared papers, 2015–2026 · strength 0.40
  4. Sunao Uemura · 1 shared paper, 2026 · strength 0.29
  5. Shinya Sakamoto · 1 shared paper, 2026 · strength 0.29
  6. Shuta Tamura · 1 shared paper, 2026 · strength 0.29
  7. Yasuo Shima · 2 shared papers, 2015–2017 · strength 0.11
  8. Tatsuaki Sumiyoshi · 2 shared papers, 2015–2017 · strength 0.11
  9. Akihito Nishioka · 1 shared paper, 2017 · strength 0.06
  10. Yasuhiro Shimada · 1 shared paper, 2017 · strength 0.06
  11. Kenta Sui · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.